128 related articles for article (PubMed ID: 10800096)
1. Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta.
Annenkov A; Chernajovsky Y
Gene Ther; 2000 Apr; 7(8):714-22. PubMed ID: 10800096
[TBL] [Abstract][Full Text] [Related]
2. Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit.
Annenkov AE; Moyes SP; Eshhar Z; Mageed RA; Chernajovsky Y
J Immunol; 1998 Dec; 161(12):6604-13. PubMed ID: 9862688
[TBL] [Abstract][Full Text] [Related]
3. A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.
Moritz D; Groner B
Gene Ther; 1995 Oct; 2(8):539-46. PubMed ID: 8593604
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression.
Altenschmidt U; Klundt E; Groner B
J Immunol; 1997 Dec; 159(11):5509-15. PubMed ID: 9548491
[TBL] [Abstract][Full Text] [Related]
5. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
Altenschmidt U; Kahl R; Moritz D; Schnierle BS; Gerstmayer B; Wels W; Groner B
Clin Cancer Res; 1996 Jun; 2(6):1001-8. PubMed ID: 9816261
[TBL] [Abstract][Full Text] [Related]
6. T cell regulation of collagen-induced arthritis in mice. III. Is T cell vaccination a valuable therapy?
Chiocchia G; Manoury-Schwartz B; Boissier MC; Gahery H; Marche PN; Fournier C
Eur J Immunol; 1994 Nov; 24(11):2775-83. PubMed ID: 7525304
[TBL] [Abstract][Full Text] [Related]
7. Characterization of signal transduction through the TCR-zeta chain following T cell stimulation with analogue peptides of type II collagen 260-267.
Tang B; Myers LK; Rosloniec EF; Whittington KB; Stuart JM; Kang AH
J Immunol; 1998 Apr; 160(7):3135-42. PubMed ID: 9531268
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific targeting of CD8+ T cells with receptor-modified T lymphocytes.
Nguyen P; Geiger TL
Gene Ther; 2003 Apr; 10(7):594-604. PubMed ID: 12646865
[TBL] [Abstract][Full Text] [Related]
9. Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product.
Finney HM; Lawson AD; Bebbington CR; Weir AN
J Immunol; 1998 Sep; 161(6):2791-7. PubMed ID: 9743337
[TBL] [Abstract][Full Text] [Related]
10. T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.
Masiero S; Del Vecchio C; Gavioli R; Mattiuzzo G; Cusi MG; Micheli L; Gennari F; Siccardi A; Marasco WA; Palù G; Parolin C
Gene Ther; 2005 Feb; 12(4):299-310. PubMed ID: 15496956
[TBL] [Abstract][Full Text] [Related]
11. The TCR zeta-chain immunoreceptor tyrosine-based activation motifs are sufficient for the activation and differentiation of primary T lymphocytes.
Geiger TL; Leitenberg D; Flavell RA
J Immunol; 1999 May; 162(10):5931-9. PubMed ID: 10229830
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
13. Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes.
Lustgarten J; Eshhar Z
Eur J Immunol; 1995 Oct; 25(10):2985-91. PubMed ID: 7589102
[TBL] [Abstract][Full Text] [Related]
14. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
[TBL] [Abstract][Full Text] [Related]
15. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
16. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors.
Stancovski I; Schindler DG; Waks T; Yarden Y; Sela M; Eshhar Z
J Immunol; 1993 Dec; 151(11):6577-82. PubMed ID: 7902379
[TBL] [Abstract][Full Text] [Related]
17. Functional assembly of chimeric T-cell receptor chains.
Gorochov G; Lustgarten J; Waks T; Gross G; Eshhar Z
Int J Cancer Suppl; 1992; 7():53-7. PubMed ID: 1428405
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA.
Kuroki M; Arakawa F; Khare PD; Kuroki M; Liao S; Matsumoto H; Abe H; Imakiire T
Anticancer Res; 2000; 20(6A):4067-71. PubMed ID: 11131674
[TBL] [Abstract][Full Text] [Related]
19. Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma.
Gonzalez S; Naranjo A; Serrano LM; Chang WC; Wright CL; Jensen MC
J Gene Med; 2004 Jun; 6(6):704-11. PubMed ID: 15170741
[TBL] [Abstract][Full Text] [Related]
20. Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes.
Jyothi MD; Flavell RA; Geiger TL
Nat Biotechnol; 2002 Dec; 20(12):1215-20. PubMed ID: 12426577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
